Optimizing recellularization of whole decellularized heart extracellular matrix

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Robertson, Matthew J ^a,b   Dries Devlin, Jessica L ^c   Kren, Stefan M ^a   Burchfield, Jana S ^b   Taylor, Doris A ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b TEXAS HEART INSTITUTE   (United States)

^c Medtronic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; TISSUE SCAFFOLD; VON WILLEBRAND FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; BRACHIOCEPHALIC TRUNK; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FEMALE; HEART; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE WALL; IN VITRO STUDY; IN VIVO STUDY; INFERIOR CAVA VEIN; MALE; NEWBORN; NONHUMAN; RAT; THROMBOGENICITY;

ANIMALS; AORTA; CADAVER; CELL PROLIFERATION; CELL SURVIVAL; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; FEMALE; HEART VENTRICLES; MYOCARDIAL REPERFUSION; MYOCARDIUM; NITRIC OXIDE SYNTHASE TYPE III; RATS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84896333307     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090406     Document Type: Article

References (32)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, et al. (2013) Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 127: e6-e245.
2. Dean EW, Udelsman B, Breuer CK (2012) Current advances in the translation of vascular tissue engineering to the treatment of pediatric congenital heart disease. Yale J Biol Med 85: 229-238.
3. Butcher JT, Mahler GJ, Hockaday LA (2011) Aortic valve disease and treatment: the need for naturally engineered solutions. Adv Drug Deliv Rev 63: 242-268.
4. Karikkineth BC, Zimmermann WH (2013) Myocardial tissue engineering and heart muscle repair. Curr Pharm Biotechnol 14: 4-11.
5. Gaballa MA, Sunkomat JN, Thai H, Morkin E, Ewy G, et al. (2006) Grafting an acellular 3-dimensional collagen scaffold onto a non-transmural infarcted myocardium induces neo-angiogenesis and reduces cardiac remodeling. J Heart Lung Transplant 25: 946-954. (Pubitemid 44144592)
6. Kochupura PV, Azeloglu EU, Kelly DJ, Doronin SV, Badylak SF, et al. (2005) Tissue-engineered myocardial patch derived from extracellular matrix provides regional mechanical function. Circulation 112: I144-149. (Pubitemid 41266666)
7. Kutschka I, Chen IY, Kofidis T, Arai T, von Degenfeld G, et al. (2006) Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts. Circulation 114: I167-173. (Pubitemid 44297146)
8. Zimmermann WH, Melnychenko I, Wasmeier G, Didie M, Naito H, et al. (2006) Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 12: 452-458.
9. Vunjak-Novakovic G, Tandon N, Godier A, Maidhof R, Marsano A, et al. (2009) Challenges in Cardiac Tissue Engineering. Tissue Eng Part B Rev.
10. Korecky B, Hai CM, Rakusan K (1982) Functional capillary density in normal and transplanted rat hearts. Can J Physiol Pharmacol 60: 23-32. (Pubitemid 12184128)
11. Morritt AN, Bortolotto SK, Dilley RJ, Han X, Kompa AR, et al. (2007) Cardiac tissue engineering in an in vivo vascularized chamber. Circulation 115: 353-360. (Pubitemid 46148509)
12. Radisic M, Marsano A, Maidhof R, Wang Y, Vunjak-Novakovic G (2008) Cardiac tissue engineering using perfusion bioreactor systems. Nat Protoc 3: 719-738. (Pubitemid 351516766)
13. Kim MH, Hong HN, Hong JP, Park CJ, Kwon SW, et al. (2009) The effect of VEGF on the myogenic differentiation of adipose tissue derived stem cells within thermosensitive hydrogel matrices. Biomaterials 31: 1213-1218.
14. Nillesen ST, Geutjes PJ, Wismans R, Schalkwijk J, Daamen WF, et al. (2007) Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF. Biomaterials 28: 1123-1131. (Pubitemid 44809425)
15. Ota T, Sawa Y, Iwai S, Kitajima T, Ueda Y, et al. (2005) Fibronectin-hepatocyte growth factor enhances reendothelialization in tissue-engineered heart valve. Ann Thorac Surg 80: 1794-1801. (Pubitemid 41464302)
16. Zhang Z, Dong H, Liu J, Wang W, Hu B (2002) Vascular endothelial growth factor gene transfer improves host endothelialization of xenogeneic biologic heart valve in vivo. Chin Med J (Engl) 115: 878-883. (Pubitemid 34716402)
17. Zisch AH, Schenk U, Schense JC, Sakiyama-Elbert SE, Hubbell JA (2001) Covalently conjugated VEGF-fibrin matrices for endothelialization. J Control Release 72: 101-113. (Pubitemid 32522348)
18. Caspi O, Lesman A, Basevitch Y, Gepstein A, Arbel G, et al. (2007) Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res 100: 263-272. (Pubitemid 46208727)
19. Suuronen EJ, Veinot JP, Wong S, Kapila V, Price J, et al. (2006) Tissue-engineered injectable collagen-based matrices for improved cell delivery and vascularization of ischemic tissue using CD133+ progenitors expanded from the peripheral blood. Circulation 114: I138-144. (Pubitemid 44297142)
20. Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, et al. (2008) Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 14: 213-221. (Pubitemid 351214548)
21. Aubin H, Kranz A, Hulsmann J, Lichtenberg A, Akhyari P (2013) Decellularized whole heart for bioartificial heart. Methods Mol Biol 1036: 163-178.
22. Park KM, Woo HM (2012) Systemic decellularization for multi-organ scaffolds in rats. Transplant Proc 44: 1151-1154.
23. Wainwright JM, Czajka CA, Patel UB, Freytes DO, Tobita K, et al. (2010) Preparation of cardiac extracellular matrix from an intact porcine heart. Tissue Eng Part C Methods 16: 525-532.
24. Lu TY, Lin B, Kim J, Sullivan M, Tobita K, et al. (2013) Repopulation of decellularized mouse heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells. Nat Commun 4: 2307.
25. Strater J, Gunthert AR, Bruderlein S, Moller P (1995) Microwave irradiation of paraffin-embedded tissue sensitizes the TUNEL method for in situ detection of apoptotic cells. Histochem Cell Biol 103: 157-160.
26. Calnek DS, Grinnell BW (1998) Thrombomodulin-Dependent Anticoagulant Activity Is Regulated by Vascular Endothelial Growth Factor. Experimental Cell Research 238: 294-298. (Pubitemid 28366153)
27. Ibrahim S, Ramamurthi A (2008) Hyaluronic acid cues for functional endothelialization of vascular constructs. J Tissue Eng Regen Med.
28. Ono K, Lindsey ES (1969) Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 57: 225-229.
29. Donovan D, Brown NJ, Bishop ET, Lewis CE (2001) Comparison of three in vitro human 'angiogenesis' assays with capillaries formed in vivo. Angiogenesis 4: 113-121. (Pubitemid 34032697)
30. Robinson CJ, Mulloy B, Gallagher JT, Stringer SE (2006) VEGF165-binding sites within heparan sulfate encompass two highly sulfated domains and can be liberated by K5 lyase. J Biol Chem 281: 1731-1740.
31. Mbemba E, Gluckman JC, Gattegno L (2000) Glycan and glycosaminoglycan binding properties of stromal cell-derived factor (SDF)-1alpha. Glycobiology 10: 21-29. (Pubitemid 30122196)
32. Narmoneva DA, Vukmirovic R, Davis ME, Kamm RD, Lee RT (2004) Endothelial cells promote cardiac myocyte survival and spatial reorganization: implications for cardiac regeneration. Circulation 110: 962-968. (Pubitemid 39136214)